<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib37">
 <element-citation publication-type="journal" id="sref37">
  <person-group person-group-type="author">
   <name>
    <surname>Monteil</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Kwon</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Prado</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Hagelkru?ys</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Wimmer</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Stahl</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Leopoldi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Garreta</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Hurtado del Pozo</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Prosper</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2</article-title>
  <source>Cell</source>
  <volume>181</volume>
  <year>2020</year>
  <fpage>905</fpage>
  <lpage>913.e7</lpage>
  <pub-id pub-id-type="pmid">32333836</pub-id>
 </element-citation>
</ref>
